|

[Ac 225]RTX-2358 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Ratio Therapeutics, Inc.1

Indications

  • Advanced Soft-tissue Sarcoma1
  • Cancer1

Los Angeles, California1 trial

Actinium Therapy for Late-stage Aggressive Sarcomas

UCLA

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.